Intraoperative Dexmedetomidine Reduces Postoperative Delirium in Pediatric Patients

Strategic Insights -

A study published in BMC Pediatrics has shown that intraoperative dexmedetomidine significantly reduces the incidence of postoperative delirium (POD) in pediatric patients undergoing lower extremity orthopedic surgery. The research, conducted at Children's Hospital of Jiangnan University in Wuxi, China, included 128 pediatric patients aged 3-12 years who underwent lower extremity orthopedic surgery and received single-shot caudal block combined with intravenous patient-controlled analgesia (IV-PCA) from January 2021 to December 2023. The study found that the incidence of POD was significantly lower in the dexmedetomidine group compared to the sufentanil group (14.1% vs. 34.4%, p = 0.01). The research concluded that intraoperative dexmedetomidine significantly reduces the incidence of POD and improves early postoperative pain control in pediatric patients undergoing lower extremity orthopedic surgery, without increasing adverse events.

Key Takeaways:

  • The study evaluated the effectiveness of intraoperative dexmedetomidine in preventing postoperative delirium (POD) in pediatric patients undergoing lower extremity orthopedic surgery.
  • The study included 128 pediatric patients aged 3-12 years who underwent lower extremity orthopedic surgery and received single-shot caudal block combined with intravenous patient-controlled analgesia (IV-PCA) from January 2021 to December 2023.
  • The incidence of POD was significantly lower in the dexmedetomidine group compared to the sufentanil group (14.1% vs. 34.4%, p = 0.01).
  • Multivariate logistic regression revealed that intraoperative dexmedetomidine was independently associated with a reduced risk of POD (OR = 0.29, 95% CI: 0.12-0.74, p = 0.01).
  • The study concluded that intraoperative dexmedetomidine significantly reduces the incidence of POD and improves early postoperative pain control in pediatric patients undergoing lower extremity orthopedic surgery, without increasing adverse events.
  • The research was conducted by Ying Han, Yiwen Sun, Wenyan Dong, Xiaoyan Zhou, Qianrong Jiang, Yongmin Mao, Shuoxiong Wu, and Guilong Wang from Children's Hospital of Jiangnan University in Wuxi, China.

Statistics:

  • 128 pediatric patients were included in the study.
  • The incidence of POD was significantly lower in the dexmedetomidine group compared to the sufentanil group (14.1% vs. 34.4%, p = 0.01).
  • Multivariate logistic regression revealed that intraoperative dexmedetomidine was independently associated with a reduced risk of POD (OR = 0.29, 95% CI: 0.12-0.74, p = 0.01).

Sources:

  • NewsRx. Research Results from Children's Hospital Update Understanding of Delirium (Intraoperative dexmedetomidine for prevention of postoperative delirium in pediatric patients after orthopedic surgery: a single-center retrospective study). Mental Health Weekly Digest. October 20, 2025; p 1579.
  • Intraoperative dexmedetomidine for prevention of postoperative delirium in pediatric patients after orthopedic surgery: a single-center retrospective study. BMC Pediatrics, 2025;25(1):779.